Preparing stock dashboard...
Preparing stock dashboard...
002262.SZ - Shenzhen - Healthcare - Drug Manufacturers - Specialty & Generic
Jiangsu Nhwa Pharmaceutical Co., LTD engages in research, development, production, and sale of central nervous system products in China. The company offers APIs, solid preparation, water injection, and freeze-dried powder formulations for depression, anxiety disorders, insomnia, severe mental disorders, and neurodegenerative diseases. Its products include sufentanil citrate injection, oxaliplatin fumarate injection, alfentanil hydrochloride injection, oxycodone hydrochloride injection, olanzapine tablets, midazolam hydrochloride oral solution, clonazepam injection, lacosamide injection, micuronium injection, pregabalin capsules, vortioxetine hydrobromide tablets, tapentadone hydrochloride tablets, and oxycodone hydrochloride extended-release tablets. The company was founded in 1978 and is headquartered in Xuzhou, China.
Data updated June 15, 2026
| Metric | Value ('000,000) |
|---|
Latest period compared with the previous period and the matching prior-year period.
Loading financial changes...
Scores this stock using the same metrics model as the compare page.
| Metric | Value | Score |
|---|
Calculated locally from stored daily price and volume history.
Loading technical analysis...
Mouse wheel or pinch to zoom. Drag chart to pan. Double-click to reset zoom.